# Research Validation Audit Report: MedGenome Deconstruction (Cycle #1)

> **Initiative:** Inside the Industry — Sageloom Analytics  
> **Review Date:** 2026-10-02  
> **Target Company:** MedGenome Labs Ltd. / MedGenome Inc.  
> **Target Intake Document:** `01-academy/inside-the-industry/cycles/cycle-01-medgenome/MedGenome_Student_Intake_Worksheet.md`  
> **Auditor / Evaluator:** Growth / Partnerships Lead & UX / Curriculum Review  
> **Overall Validation Verdict:** **PASSED (All 5 Gates Satisfied)**

---

## The 5-Point Validation Review

| Gate # | Evaluation Dimension | Passing Standard | Assessment Findings & Evidence | Status |
|:---:|:---|:---|:---|:---:|
| **1** | **Verifiable Public Sourcing** | Minimum 3 credible citations (peer-reviewed papers, patents, official documentation). Zero hallucinated URLs. | **4 high-quality verifiable citations provided:**<br>1. *Nature* (2019) GenomeAsia 100K flagship paper (DOI: 10.1038/s41586-019-1793-z).<br>2. *Cell Genomics* (2023) South Asian medical genomics cohort study (DOI: 10.1016/j.xgen.2023.100378).<br>3. *Genetics in Medicine* (2015) ACMG/AMP variant interpretation guidelines (DOI: 10.1038/gim.2015.30).<br>4. Official MedGenome technical portfolio and architecture documentation. | **PASS** |
| **2** | **Scientific & Biological Accuracy** | Correct usage of genomic, molecular, or clinical terminology; accurately explains why the problem is biologically hard. | Accurately distinguishes germline vs. somatic sequencing, cfDNA liquid biopsy challenges (<0.1% VAF), and population genetics effects (founder effects, endogamy in South Asian demographics leading to false-positive pathogenic classifications without local allele frequencies). Distinguishes SNVs, indels, CNVs, and structural rearrangements. | **PASS** |
| **3** | **Pipeline & Algorithmic Concreteness** | Distinctly identifies inputs (e.g. raw FASTQ), algorithms/tools (e.g. BWA, GATK), and outputs (e.g. annotated VCF, clinical report). Zero generic buzzwords. | Identifies exact algorithms and production tools: `bcl2fastq`/`bcl-convert`, `BWA-MEM2`, `Picard`, `GATK HaplotypeCaller` & `Mutect2`, `DeepVariant`, `VEP`, `SpliceAI`, `Nextflow`, and `Docker`. Complete data flow diagram mapped from BCL $\to$ FASTQ $\to$ BAM $\to$ VCF $\to$ Clinical PDF. | **PASS** |
| **4** | **Educational & Career Grounding** | Explicitly maps company challenges to required programming languages, bioinformatics packages, and entry-level career roles. | Specifies actionable graduate skills: Python packages (`pysam`, `pyvcf`, `biopython`, `pandas`), command-line tools (`bash`, `awk`), pipeline frameworks (`Nextflow`, `Docker`), and statistical genetics concepts (Hardy-Weinberg equilibrium, FDR control). Outlines concrete entry-level role: Junior Bioinformatician / Trainee Variant Analyst. | **PASS** |
| **5** | **Zero-Hype & Non-Promotional Tone** | Neutral, analytical tone that discusses limitations, technical trade-offs, and data challenges objectively. No marketing superlatives. | Strictly analytical and pedagogical. Excludes buzzwords such as "revolutionary", "disruptive", "world-leading", or commercial endorsements. Focuses on the engineering and clinical bottlenecks of variant interpretation. | **PASS** |

---

## Summary Recommendation for Board
The intake research adheres fully to Sageloom Analytics editorial and scientific quality standards. The research material is cleared for synthesis into the educational LinkedIn post and publication to issue document `plan` for formal Board approval.
